GlucoTrack Stock (NASDAQ:GCTK)


RevenueOwnershipFinancialsChart

Previous Close

$0.25

52W Range

$0.23 - $4.95

50D Avg

$2.01

200D Avg

$2.00

Market Cap

$1.54M

Avg Vol (3M)

$264.53K

Beta

0.16

Div Yield

-

GCTK Company Profile


GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

6

IPO Date

Apr 25, 2013

Website

GCTK Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 19Dec 18
Europe$208.46K$41.49K
Asia and Pacific$300.00$2.00K

Fiscal year ends in Dec 23 | Currency in USD

GCTK Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income$7.95M$-4.43M$-4.04M
Net Income$7.95M$-4.44M$-4.10M
EBITDA$7.95M$-4.41M$-3.88M
Basic EPS-$-0.29$-0.27
Diluted EPS-$-0.29$-0.27

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison


TickerCompany
ZJYLJin Medical International Ltd.
AVGRAvinger, Inc.
GMVDG Medical Innovations Holdings Ltd
MBOTMicrobot Medical Inc.
MHUAMeihua International Medical Technologies Co., Ltd.
POAIPredictive Oncology Inc.
LUCYInnovative Eyewear, Inc.
PDEXPro-Dex, Inc.
NXGLNEXGEL, Inc.
STSSSharps Technology, Inc.